Literature DB >> 2776013

Distribution, possible origins and fine structure of neuropeptide Y-containing nerve fibers in the rat liver.

N Inoue1, S Magari, Y Ito, M Sakanaka.   

Abstract

The distribution, possible origins and fine structure of neuropeptide Y (NPY)-containing nerve fibers in the rat liver were investigated by immunohistochemistry, nerve transection and immunoelectron microscopy. Light-microscopic immunohistochemistry showed NPY fibers forming a complex network in and around the walls (tunica adventitia and tunica media) of hepatic vessels. They were also closely associated with interlobular bile ducts. The NPY fibers in the liver were almost completely eliminated by transection of the greater splanchnic nerves just distal to the celiac ganglion. Transection of the greater splanchnic nerves just proximal to the celiac ganglion resulted in a marked decrease in NPY fibers, but a significant number remained intact. Under electron microscopy. NPY terminals without a covering of glial processes were seen not only in proximity to smooth muscle cells within the tunica media of hepatic vessels but also in the subendothelial areas of the tunica intima. Some NPY axon terminals devoid of glial ensheathment were located close to the basal lamina of interlobular bile ducts. Occasionally, single axon terminals with NPY were found in the vicinity of or in contact with hepatic cells. There was a small number of NPY fibers that had lost their glial sheaths while running toward lymphatic capillaries. These findings suggest that hepatic NPY arises from the celiac ganglion and paravertebral sympathetic ganglia, and that it is involved in more complex physiological processes than the previously described neuropeptides in the liver, which are localized exclusively to hepatic vessel walls.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2776013     DOI: 10.1016/0006-8993(89)91002-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion.

Authors:  Sharon DeMorrow; Paolo Onori; Julie Venter; Pietro Invernizzi; Gabriel Frampton; Mellanie White; Antonio Franchitto; Shelley Kopriva; Francesca Bernuzzi; Heather Francis; Monique Coufal; Shannon Glaser; Giammarco Fava; Fanyin Meng; Domenico Alvaro; Guido Carpino; Eugenio Gaudio; Gianfranco Alpini
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-26       Impact factor: 4.249

2.  An anterograde tracing study of the vagal innervation of rat liver, portal vein and biliary system.

Authors:  H R Berthoud; M Kressel; W L Neuhuber
Journal:  Anat Embryol (Berl)       Date:  1992-10

3.  Increase in immunoreactivity for endothelin-1 in blood vessels of rat liver metastases: experimental sarcoma and carcinoma.

Authors:  A Loesch; M Turmaine; M Loizidou; R Crowe; S Ashraf; I Taylor; G Burnstock
Journal:  J Anat       Date:  1997-08       Impact factor: 2.610

4.  Innervation of vasculature and microvasculature of the human vagina by NOS and neuropeptide-containing nerves.

Authors:  C H Hoyle; R W Stones; T Robson; K Whitley; G Burnstock
Journal:  J Anat       Date:  1996-06       Impact factor: 2.610

5.  Neuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms.

Authors:  Sharon DeMorrow; Fanyin Meng; Julie Venter; Dinorah Leyva-Illades; Heather Francis; Gabriel Frampton; Hae Yong Pae; Matthew Quinn; Paolo Onori; Shannon Glaser; Kelly McDaniel; Romina Mancinelli; Eugenio Gaudio; Gianfranco Alpini; Antonio Franchitto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-23       Impact factor: 4.052

6.  Blood vessels in liver metastases from both sarcoma and carcinoma lack perivascular innervation and smooth muscle cells.

Authors:  S Ashraf; M Loizidou; R Crowe; M Turmaine; I Taylor; G Burnstock
Journal:  Clin Exp Metastasis       Date:  1997-09       Impact factor: 5.150

7.  The absence of autonomic perivascular nerves in human colorectal liver metastases.

Authors:  S Ashraf; R Crowe; M C Loizidou; M Turmaine; I Taylor; G Burnstock
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.